Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies

The EU Directive 2010/63/EU on the protection of animals used for scientific purposes and other EU regulations, such as REACH and the Cosmetic Products Regulation advocate for a change in the way toxicity testing is conducted. Whilst the Cosmetic Products Regulation bans animal testing altogether, REACH aims for a progressive shift from in vivo testing towards quantitative in vitro and computational approaches. Several endpoints can already be addressed using non-animal approaches including skin corrosion and irritation, serious eye damage and irritation, skin sensitisation, and mutagenicity and genotoxicity. However, for systemic effects such as acute toxicity, repeated dose toxicity and reproductive and developmental toxicity, evaluation of chemicals under REACH still heavily relies on animal tests. Here we summarise current EU regulatory requirements for the human health assessment of chemicals under REACH and the Cosmetic Products Regulation, considering the more critical endpoints and identifying the main challenges in introducing alternative methods into regulatory testing practice. This supports a recent initiative taken by the International Cooperation on Alternative Test Methods (ICATM) to summarise current regulatory requirements specific for the assessment of chemicals and cosmetic products for several human health-related endpoints, with the aim of comparing different jurisdictions and coordinating the promotion and ultimately the implementation of non-animal approaches worldwide. Recent initiatives undertaken at European level to promote the 3Rs and the use of alternative methods in current regulatory practice are also discussed.

PISTOLLATO Francesca;  MADIA Federica Anna Carla;  CORVI Raffaella;  MUNN Sharon;  GRIGNARD Elise;  PAINI Alicia;  WORTH Andrew;  PRICE Anna;  PRIETO PERAITA Maria Del Pilar;  CASATI Silvia;  BERGGREN Elisabet;  BOPP Stephanie;  ZUANG Valerie; 

2021-06-11

SPRINGER HEIDELBERG

JRC122442

0340-5761 (online),   

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166712/pdf/204_2021_Article_3034.pdf,    https://publications.jrc.ec.europa.eu/repository/handle/JRC122442,   

10.1007/s00204-021-03034-y (online),